U.S. Software Stock News

Earlier in October 2025, Protalix BioTherapeutics and Chiesi Group received a negative opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) regarding Elfabrio’s proposed less-frequent dosing regimen for Fabry disease, as the data was considered insufficient to demonstrate similar efficacy to the currently approved schedule. This regulatory decision highlights ongoing challenges in achieving flexibility for rare disease treatments, with...

As of October 2025, the U.S. stock market has navigated a volatile week with major indices such as the Nasdaq and S&P 500 recording solid gains, despite ongoing concerns about banking sector health and geopolitical tensions. In this dynamic environment, high growth tech stocks in the U.S. remain a focal point for investors seeking opportunities that align with robust innovation trends and potential resilience amid economic fluctuations.

As the U.S. stock market concludes a volatile week with major indices posting gains, investors are navigating through concerns about banking sector health and trade tensions with China. In this environment, identifying stocks that are potentially undervalued can offer opportunities for those looking to capitalize on discrepancies between market prices and intrinsic values.

As the U.S. stock market navigates a volatile landscape marked by fluctuating indices and economic uncertainties, investors continue to seek opportunities in growth companies that demonstrate robust potential. In this context, high insider ownership often signals confidence in a company's future prospects, making such stocks particularly appealing amidst the current market dynamics.

As the U.S. markets close higher after a volatile week, investors are keenly observing opportunities that might arise amidst fluctuating conditions and economic uncertainties. Penny stocks, often seen as relics of speculative trading, still hold potential when underpinned by solid financials and growth prospects. In this article, we explore three penny stocks that exemplify strong balance sheets and promising fundamentals, offering investors a chance to uncover hidden value in companies with...

The Morning Bull - US Market Morning Update Monday, Oct, 20 2025 US market futures are pointing higher this morning, lifted by optimism around easing trade tensions and a dip in long-term interest rates. Investors are weighing improved fiscal data against the backdrop of a prolonged government shutdown. There is continued caution as uncertainty shapes expectations for growth and puts pressure on consumer-focused names to deliver steady performance. Uncertainty favors prepared investors. Act...

Insiders who purchased Fossil Group, Inc. ( NASDAQ:FOSL ) shares in the past 12 months are unlikely to be deeply...

Dominari Holdings Inc. ( NASDAQ:DOMH ) shareholders might be concerned after seeing the share price drop 15% in the...

Casella Waste Systems, Inc. ( NASDAQ:CWST ), might not be a large cap stock, but it saw significant share price...

Achieve Life Sciences recently announced that the U.S. Food and Drug Administration awarded the company a rare Commissioner's National Priority Voucher, expediting the review of cytisinicline for nicotine dependence in e-cigarette or vaping cessation. This first-of-its-kind designation, paired with Breakthrough Therapy status and promising clinical trial results, puts cytisinicline at the forefront of developing a dedicated treatment for vaping cessation, an area with significant unmet...

Rekor Systems announced in October 2025 that the California and Texas Departments of Transportation have begun using Rekor Discover®, following its largest statewide contract to date with the Georgia DOT, which could reach over US$100 million in value. This sequence of wins, including a recent technology award and initial order in South Carolina, highlights Rekor's growing traction with state transportation agencies and the increasing relevance of its AI-powered data solutions for modern...

NETGEAR (NTGR) shares have seen some interesting movement recently, with the stock gaining over 13% in the past month. Investors may be weighing the company’s steady annual revenue growth as well as ongoing changes in the tech sector. See our latest analysis for NETGEAR. While NETGEAR's 1-month share price return of 13.2% signals renewed momentum, the stock's 1-year total shareholder return stands at an impressive 50.7%. This suggests that although gains have recently accelerated, long-term...

Thinking about what to do next with BioLife Solutions stock? You are not alone. Over the past year, shares have quietly climbed 15.6%, and while that performance might catch your eye, it is the bigger context that makes this stock so interesting right now. Investors have watched it rebound 6.8% in just the last 30 days, adding to a 4.4% gain year-to-date. Yet, when looking further back, the five-year total return lags at -5.9%, painting a far more complex picture. So, what is driving this...

Cryoport, Inc. recently unveiled new integrated condition monitoring solutions for its MVE Biological Solutions dewars, incorporating the SmartTag and CryoBeacon devices powered by Tec4Med, with data centralized in the FDA-compliant MVECloud platform for enhanced monitoring of cryogenic storage. This innovation offers life sciences companies real-time visibility and improved safety for temperature-sensitive commodities, reflecting an ongoing push toward advanced digital and compliance...

Quantum-Si recently introduced its V4 Sequencing Kit, designed to enhance protein analysis by expanding sequencing coverage and improving detection of specific amino acids. This technological advance stands out for its potential to significantly strengthen the company’s protein sequencing platform in the evolving life sciences sector. We'll look at how the V4 Sequencing Kit's improved capabilities shape Quantum-Si's investment narrative amid shifting market attention. Find companies with...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

AVITA Medical (RCEL) shares have drawn attention after Chairman Cary Vance was named Interim CEO, replacing Jim Corbett. This leadership shift comes as preliminary third-quarter revenue comes in below expectations and ongoing talks with lenders continue. See our latest analysis for AVITA Medical. Shares of AVITA Medical have struggled through 2025, with the 1-day share price return plunging 25.84% after the CEO transition and softer revenue update. Short-term momentum has clearly faded. With...

Key Insights Williams Companies' estimated fair value is US$68.22 based on 2 Stage Free Cash Flow to Equity With...

We'd be surprised if Byrna Technologies Inc. ( NASDAQ:BYRN ) shareholders haven't noticed that the Independent...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Dogness (International) (DOGZ) remains unprofitable, with losses having grown at a compounded rate of 13.9% annually over the past five years. The company’s net profit margin has failed to improve, and there are no signs of a turnaround or positive profit growth in recent periods. See our full analysis for Dogness (International). Next, we will see how the latest numbers measure up against the key narratives followed by the market. We will also consider whether popular views on DOGZ are still...

On October 17, 2025, Veritex Holdings, Inc. was removed from multiple Russell indices, including the Russell 2000, Russell 3000, and several value and defensive benchmarks. This broad index exclusion can prompt adjustments by passive funds and ETFs, often amplifying market pressures on a company's shares, independent of its fundamental performance. We'll examine how Veritex Holdings' widespread index removals may affect its investment outlook, particularly amid heightened regional bank...

Cricut (CRCT) stock has been on investors’ radar lately as its shares edged up slightly over the past week, despite a dip of 21% over the past month. This price movement has some market watchers examining its recent trends and valuation. See our latest analysis for Cricut. While Cricut’s 1-year total shareholder return sits at -11.1% and its share price is down more than 20% in the past month, these moves fit a broader trend as momentum has faded after a stronger start to the year. The most...